Healthcare Web Wire

Author: Elena Morales

Cold Storage Market Key Players and Trends
Cold Storage Market Growth and Outlook (2023 – 2032)

The global cold storage market is expected to grow from USD 112 billion in 2022 to USD 383.05 billion by 2032, driven by demand in the food and pharmaceutical sectors, with a CAGR of 12%.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5047

Growth of Outsourcing and Consolidation in the Cold Storage Market

Outsourcing continues to rise across industries, with third-party logistics (3PL) providers now accounting for 34% of all leasing activity, up from 30% last year. This shift is particularly evident in the cold storage sector, where the complexity of technology and high operational costs are driving more companies to depend on 3PL providers.

Since 2019, consolidation in the public refrigerated warehouse (PRW) industry has accelerated. Back then, Lineage Logistics and Americold controlled 61% of North America’s cold storage space. Today, they manage 71%, with United States Cold Storage holding an additional 10%. This consolidation has resulted in a few major players dominating the industry. As technology improves, larger companies are benefiting from economies of scale, making the challenges of managing larger operations more manageable.

Population growth and demographic shifts are also fueling the demand for cold storage. As people move to states like Florida, Arizona, and Texas, the need for cold storage to support the increasing demand for food and beverages is growing.

A key driver of the market is the rise of online grocery shopping, particularly for perishable items like frozen snacks, meat, and poultry. Although perishable goods make up a smaller portion of total online grocery sales, their share is growing. By October 2021, refrigerated and frozen foods represented 9% and 13% of e-commerce grocery sales, respectively, up from just 4% each in early 2020. Online purchases of these items also saw a 58% year-over-year increase by October 2021.

Key Players in the Cold Storage Market
- Americold Logistics: A global leader in temperature-controlled warehousing and logistics, Americold operates one of the largest networks of cold storage facilities. They provide services to a variety of industries, with a strong presence in North America.
- Lineage Logistics Holdings: As one of the largest temperature-controlled logistics companies in the world, Lineage Logistics offers cold storage and supply chain solutions to the food and pharmaceutical industries. Their vast network of facilities and advanced technologies enable efficient handling and distribution.
- Nichirei Corporation: A major Japanese food company, Nichirei has a significant presence in the cold storage sector, specializing in frozen food distribution and temperature-controlled warehousing. Their services extend to logistics and supply chain management for food products.
- Burris Logistics: Burris Logistics provides integrated cold storage and distribution solutions to food producers, retailers, and restaurants. They are known for their efficiency in handling perishables and offering tailored services to meet the needs of the food industry.
- Agro Merchants Group: Specializing in refrigerated logistics, Agro Merchants Group offers a wide range of cold storage services, with a global presence. Their facilities are strategically located to support the transportation and distribution of perishable goods across various regions.
- Kloosterboer: A leading provider of cold storage and refrigerated logistics services, Kloosterboer operates facilities across Europe and North America. Their services cater to the food industry, ensuring the safe storage and handling of frozen and chilled goods.
- United States Cold Storage: A major player in North America, United States Cold Storage operates a vast network of cold storage facilities that support the food industry. They focus on providing reliable and efficient storage, handling, and distribution services.
- Tippmann Group: Tippmann Group is a well-established provider of cold storage and logistics services, offering custom solutions to meet the needs of the food and beverage industry. They also focus on designing and developing advanced cold storage facilities.
- VersaCold Logistics Services: Operating primarily in Canada, VersaCold is a leader in temperature-controlled logistics. The company provides warehousing, distribution, and transportation solutions to the food industry, with a strong emphasis on sustainability and efficiency.
- Henningsen Cold Storage Co: A leading provider of cold storage solutions in the U.S., Henningsen Cold Storage Co focuses on delivering high-quality temperature-controlled storage for a variety of perishable goods, including food and pharmaceuticals.
- Coldman: Based in Europe, Coldman specializes in providing temperature-controlled storage services for perishable goods. The company’s solutions support various industries, including food and pharmaceuticals, offering integrated logistics services.
- Congebec Inc.: A Canadian company offering cold storage and logistics solutions, Congebec Inc. specializes in providing temperature-controlled warehousing and distribution services for the food and beverage industry.
- Conestoga Cold Storage: Operating in the United States and Canada, Conestoga Cold Storage offers customized cold storage solutions, including multi-temperature facilities and distribution services for perishable goods.
- NewCold: A global provider of cold storage and logistics services, NewCold operates highly automated, energy-efficient facilities. They focus on providing integrated supply chain solutions, including warehousing, transportation, and distribution for perishable goods.
- Hanson Logistics: Specializing in cold storage and logistics services for the food industry, Hanson Logistics provides temperature-controlled warehousing, transportation, and distribution solutions. Their services support a wide range of perishable products, including frozen and chilled foods.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/technological-revolution-transforming-the-cold-storage-market

Access exclusive insight now @ https://www.towardshealthcare.com/price/5047

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
November 29, 2024
AI in Genomics Market Key Companies and Innovations
AI in Genomics Market Growth and Outlook

The AI in genomics market, valued at USD 397.64 million in 2022, is expected to grow at a CAGR of 23.6% from 2023 to 2032, reaching an estimated USD 7,365.59 million. This growth is fueled by rising cross-industry collaborations and increased R&D investments.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5046

Building a Smarter Healthcare System Government Funding Boosts AI Research

The NHS AI Lab’s AI and Health and Care Awards initiative is designed to promote the responsible use of artificial intelligence in healthcare. Recognizing AI’s transformative potential, the awards aim to accelerate the safe and ethical adoption of AI technologies to improve patient outcomes and healthcare delivery. By supporting innovative AI projects, the program works towards enhancing care and advancing the health sector through collaboration with various stakeholders.

In May 2023, the U.S. National Science Foundation (NSF) expanded its National Artificial Intelligence Research Institutes initiative, adding 11 new institutes, bringing the total to 18. This expansion comes with a $220 million investment, enabling the institutes to extend their reach across the country.

As part of the AI and Health and Care Awards, about $138 million has been invested in 86 AI technologies through three rounds of funding. These technologies have already benefited over 300,000 patients, leading to improvements in the treatment of cancer, heart disease, diabetes, mental health, and neurological disorders. These investments are helping to develop AI solutions that could revolutionize healthcare, improving diagnosis, treatment, and patient care.

In the third round of the AI in Health and Care Awards, nine companies were granted funding to accelerate the testing and deployment of promising AI technologies in healthcare. Since its launch in 2019, the program has focused on supporting AI solutions for managing long-term conditions, speeding up diagnosis, and addressing challenges like backlogs from the COVID-19 pandemic. These awarded companies are poised to play a key role in improving patient outcomes and healthcare delivery.

In 2021, Deep Genomics, an AI-driven drug discovery company, raised $180 million in Series C funding to advance its AI-discovered drug programs for genetic diseases into clinical development. Additionally, in the same year, the National Human Genome Research Institute (NHGRI) launched the Genomics Research Elucidates Genetics of Rare Disease (GREGoR) Consortium, with a nearly $80 million investment over five years to tackle rare genetic diseases. This initiative aims to identify the genetic causes of these diseases and improve diagnosis, treatment, and care for affected individuals.

AI in Genomics Market Key Companies

The AI in genomics market is seeing significant contributions from a range of leading companies applying artificial intelligence to revolutionize genetic research, healthcare, and drug discovery. These companies are working to enhance the analysis of genomic data and improve patient outcomes through AI-driven solutions.
1. IBM – Known for its leadership in technology, IBM is applying AI and machine learning to genomics, focusing on improving drug discovery and personalized medicine through data analysis.
2. NVIDIA Corporation – A major player in AI and GPU technologies, NVIDIA provides powerful tools that enable high-performance computing in genomics, supporting applications like DNA sequencing and analysis.
3. Benevolent AI – This company uses AI to accelerate drug discovery by analyzing vast amounts of biomedical data, including genetic information, to uncover potential treatments for diseases.
4. Verge Genomics – Verge Genomics is focused on applying AI to understand the genetic basis of neurodegenerative diseases and using this knowledge to discover new drugs.
5. MolecularMatch, Inc. – MolecularMatch provides AI-driven solutions to match patients with the right treatments by analyzing genomic data and clinical trial information.
6. SOPHiA GENETICS – This company uses AI to enhance the analysis of genomic and clinical data, aiming to improve diagnostic accuracy and personalize treatment plans for patients.
7. PrecisionLife Ltd. – PrecisionLife is focused on leveraging AI to analyze complex genomic data to better understand diseases and create more targeted therapies, especially in areas like cancer and chronic diseases.
8. Lifebit – Lifebit’s AI-driven platform enables the seamless analysis of genomic and clinical data, offering solutions for drug discovery, diagnostics, and personalized medicine.
9. FDNA, Inc. – FDNA uses AI to help diagnose genetic disorders by analyzing facial features and genomic data, providing a faster and more accurate path to diagnosis.
10. Empiric Logic – Empiric Logic is developing AI-based solutions to analyze genomic and clinical data to uncover insights for better understanding diseases and creating personalized treatment strategies.
11. Microsoft – Microsoft is integrating AI technologies with genomic research, leveraging cloud computing and machine learning to advance the field of genomics and precision medicine.
12. Deep Genomics – Deep Genomics uses AI to identify new genetic disease treatments and accelerate the drug discovery process, focusing on genetic diseases and RNA-based therapies.
13. Fabric Genomics Inc. – This company focuses on using AI to analyze genomic data for precision medicine, helping healthcare providers make more informed decisions about patient care.
14. Freenome Holdings, Inc. – Freenome applies AI to blood-based testing, using genomics and machine learning to detect early-stage cancers and improve diagnostic accuracy.
15. Cambridge Cancer Genomics – This company uses AI to analyze genomic data and identify biomarkers for cancer, helping to accelerate drug discovery and improve cancer treatment strategies.
16. Data4Cure Inc. – Data4Cure focuses on using AI to analyze large-scale genomic data to identify biomarkers for diseases and assist in precision medicine.
17. Engine Biosciences Pte. Ltd – Engine Biosciences uses AI-driven drug discovery to identify new targets and treatments for complex diseases by analyzing genomic data at scale.
18. Genoox Ltd. – Genoox applies AI to clinical genomics, offering tools that help healthcare providers and researchers analyze genetic data for better diagnoses and treatments.
19. Diploid – Diploid uses AI to process genomic data for personalized medicine, helping clinicians provide tailored treatment plans based on individual genetic profiles.
20. DNAnexus Inc. – DNAnexus provides a cloud-based platform that combines AI and genomics to help researchers analyze vast amounts of genomic data, accelerating drug discovery and precision medicine efforts.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/ai-in-genomics-market

Access exclusive insight now @ https://www.towardshealthcare.com/price/5046

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
November 29, 2024
Smart Healthcare Market Revolutionizing Patient Care with Technology
Smart Healthcare Market Growth and Outlook

The global smart healthcare market is expected to grow from USD 201.83 billion in 2022 to USD 1,097.27 billion by 2032, at a CAGR of 18.5%, driven by the increasing adoption of telemedicine.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5042

From Passive Patients to Active Participants How Technology is Transforming Healthcare

The smart healthcare market involves using advanced technologies like artificial intelligence (AI), the Internet of Things (IoT), and big data to improve healthcare services’ quality and efficiency. Key solutions in this market include telemedicine, electronic health records (EHR), remote patient monitoring, and health information exchange (HIE).

Several factors are driving the growth of this market, including the increasing demand for healthcare, the rise in chronic diseases, the growing adoption of digital health solutions, and the need to reduce healthcare costs. These technologies not only improve patient outcomes but also enhance the overall patient experience and boost operational efficiency in healthcare organizations.

Key Trends Shaping Smart Healthcare
- Telemedicine: Telemedicine, which enables remote diagnosis and treatment, is expected to lead the market. It addresses challenges like the shortage of healthcare professionals, the need for chronic disease monitoring, and the demand for virtual consultations.
- Remote Monitoring and Automation: Technologies like connected inhalers and fitness trackers that monitor vital health metrics are making healthcare more proactive. For example, 66% of asthma deaths could be prevented with smart technology that monitors patients remotely, allowing for early intervention.
- Telehealth and Remote Care: Telehealth is becoming increasingly popular, with high satisfaction rates from patients (up to 78%) and strong interest from doctors (68%) in expanding remote consultations.
- AI in Healthcare: Artificial intelligence is being adopted more in healthcare, offering potential savings of up to $360 billion annually. AI tools assist with diagnostics, treatment planning, and operational improvements, transforming healthcare delivery.
- Connected Emergency Response: Smart technology in emergency response systems is improving response times. Real-time data sharing between ambulances, hospitals, and emergency departments is enhancing coordination during critical situations.
- Smart Hospital Management: Hospitals are integrating smart systems to streamline operations. These systems manage resources like beds, equipment, and supplies, improving both workflow efficiency and patient care.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/smart-healthcare-market-new-technology-meets-medicine

Access exclusive insight now @ https://www.towardshealthcare.com/insights/smart-healthcare-market-new-technology-meets-medicine

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
November 29, 2024
AI in Life Science Market Growth, Trends and Future Outlook

AI in Life Sciences Market Growth, Trends and Future Outlook

The number of partnerships between major pharmaceutical companies and AI technology providers for drug discovery surged significantly, rising from just 4 in 2015 to 27 in 2020—an impressive 575% increase over just six years.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5043

Boosting Drug Discovery with AI Technology

The demand for quicker drug discovery is a key driver behind the growth of AI in the life sciences market. Traditional drug discovery is a long and costly process, often taking years and costing billions of dollars. AI technology helps speed up this process by quickly identifying potential drug candidates and predicting their effectiveness and safety, allowing researchers to focus on the most promising options.

Many companies are teaming up with pharmaceutical and biotech firms to enhance drug discovery using AI, which is fueling growth in the life sciences sector. For example, in October 2022, BenevolentAI, a clinical-stage AI drug discovery company, expanded its partnership with AstraZeneca. The goal of the collaboration is to combine BenevolentAI’s AI-powered drug discovery platform with AstraZeneca’s expertise in disease research to find new therapeutic targets.

By leveraging AI, drug discovery can become more efficient and cost-effective, potentially speeding up the development of life-saving treatments. This has become especially crucial in light of global health crises, like the COVID-19 pandemic, where there is an urgent need for new therapies and vaccines.

AI is Revolutionizing Clinical Trials in Life Sciences

AI is driving significant changes in the life sciences industry, especially when it comes to next-generation clinical trials. By analyzing large amounts of data from various sources like electronic health records, genomics, wearable devices, and clinical trial data, AI helps identify key patient groups, predict how patients might respond to treatments, and optimize clinical trial designs. This use of AI in clinical trials is expected to grow as the number of trials increases, further boosting demand for AI tools in the life sciences sector.

AI-powered clinical trials can save pharmaceutical companies both time and money. AI algorithms help identify promising drug candidates early in the development process, preventing the waste of resources on treatments that are unlikely to succeed. Additionally, AI can optimize trial designs, speeding up patient recruitment and reducing trial costs. Overall, AI is helping to streamline drug development and increase the likelihood of success for new treatments.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/ai-in-life-science-market

Access exclusive insight now @ https://www.towardshealthcare.com/price/5043

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

November 29, 2024
Health and Wellness Market Report Trends and Challenges

Global Health and Wellness Market Overview Trends, and Forecast

The global health and wellness market, valued at USD 5.24 trillion in 2022, is projected to expand at a compound annual growth rate (CAGR) of 5.46% from 2023 to 2032. By 2032, the market is expected to reach approximately USD 8.94 trillion.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5039

Rising Consumer Interest and Purchasing Power Drive Growth in the Healthcare and Wellness Market

The healthcare and wellness market is a diverse industry that includes products and services aimed at improving physical, mental, and emotional well-being. This encompasses fitness and nutrition items, personal care and beauty products, alternative medicine, spa treatments, and more. A key driver of growth in this market is the increasing focus on preventative healthcare, as consumers seek ways to stay healthy and prevent illness. The growing prevalence of chronic diseases like diabetes, heart disease, and obesity has heightened awareness about the importance of making healthy lifestyle choices.

Additionally, the aging population and a rising interest in healthy aging have spurred demand for products and services that address age-related concerns. The advent of technology, including fitness trackers and wearables, has also played a crucial role, offering consumers new ways to monitor and manage their health.

Asia Pacific Leads the Charge: Rapid Growth in the Health and Wellness Market

The health and wellness market is poised for significant expansion, with Asia Pacific at the forefront of this growth. Factors such as the increasing prevalence of chronic diseases, rising healthcare costs, and greater awareness of the importance of healthy living are fueling demand for wellness products and services in the region.

Countries like China and India are seeing particularly strong growth, driven by a rapidly expanding middle class, urbanization, and rising disposable incomes. In 2022, Asia Pacific accounted for 30.95% of the global market share, and it is expected to increase to 31.26% by 2032, with a projected annual growth rate of 5.0% from 2023 to 2032.

The Cost Barrier: A Major Obstacle to Accessing Health and Wellness

A significant challenge in the health and wellness market is the cost barrier, which makes it difficult for many consumers to access essential products and services. Healthy foods, supplements, and fitness programs can be expensive, putting them out of reach for people with lower incomes and limiting their ability to prioritize their health.

In addition to the high cost of wellness products, healthcare expenses, including medical procedures and medications, can be a major financial burden for individuals and families. This can prevent many people from seeking necessary medical care, often leading to a lack of preventative treatment and the development of more serious health issues over time.

Another issue is the limited availability of health and wellness resources in certain areas, particularly in rural or low-income communities. These areas often lack access to affordable healthy food, fitness centers, and healthcare services, making it even harder for individuals to maintain a healthy lifestyle.

The cost barrier remains a significant obstacle in the health and wellness market, creating disparities in healthcare access and outcomes. To address this, it will be important to focus on making health and wellness products and services more affordable and accessible, especially in underserved communities.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/health-and-wellness-market-exploring-the-self-care

Access exclusive insight now @ https://www.towardshealthcare.com/price/5039

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare

November 29, 2024
Hospital Services Market Embracing Value-Based Care and Emerging Opportunities
Analysis of the Hospital Services Market: Trends and Growth Forecast

The hospital services market, valued at approximately USD 9.29 trillion in 2022, is expected to grow at a compound annual growth rate (CAGR) of 9.15% from 2023 to 2032. By 2032, the market is projected to reach USD 21.27 trillion. This growth is driven by technological advancements and a rising emphasis on health management strategies.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5041
Digital Transformation in Hospital Services

Technology is revolutionizing hospital services, improving both patient care and operational efficiency. Digital tools like electronic health records (EHR), telemedicine, and mobile health apps enable faster, more accurate diagnoses and remote monitoring, enhancing the patient experience. These technologies also help hospitals streamline operations, reduce costs, and improve medical device effectiveness through advancements in AI, robotics, and 3D printing.

Shifting Focus to Health Management

Healthcare is shifting from treating illness to managing health. This proactive approach includes regular check-ups, preventive measures, and lifestyle changes to reduce the risk of chronic diseases. Wearable devices and mobile health apps empower individuals to track their health, while health management programs are focusing on prevention and early intervention to improve outcomes and reduce costs.

Shifting to a Value-Based Model: New Opportunities in the Hospital Services Market

The healthcare industry is moving away from the traditional fee-for-service model towards a value-based model, which emphasizes better health outcomes and cost reduction. This shift creates significant opportunities for the hospital services market.

Hospitals can adopt care coordination strategies to ensure patients receive the right care at the right time. By improving communication between primary care physicians, specialists, and hospital staff, hospitals can provide more comprehensive care. Technology also plays a key role in improving efficiency and cutting costs, such as using electronic health records (EHRs) to manage patient data more effectively or offering telehealth services for remote consultations and follow-ups.

Hospitals can further enhance patient outcomes and satisfaction by offering services like patient education, wellness programs, and patient-centered care. A focus on these areas can lead to improved financial performance in a value-based care model.

Additionally, hospitals can collaborate with insurers and other healthcare providers to implement value-based payment models that reward high-quality care and positive outcomes. Working together to achieve shared goals can help hospitals improve patient outcomes, reduce costs, and boost financial success.

Leading Companies in the Hospital Services Market

Mayo Clinic

HCA Healthcare

Cleveland Clinic

Spire Healthcare Group

Ramsay Health Care

Ascension Health

Community Health Systems

Tenet Healthcare

Fortis Healthcare

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/hospital-services-market-transformation-from-treatment-to-health-management

Access exclusive insight now @ https://www.towardshealthcare.com/price/5041

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
November 29, 2024
Biosimilars Market Report Growth, Trends and Future Outlook
Biosimilars Market Growth and Outlook

The global biosimilars market, valued at USD 25.1 billion in 2022, is projected to grow at a 17.6% CAGR, reaching USD 126 billion by 2032. This growth is driven by the rising cancer rates and the demand for cost-effective treatments.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5035

The Growing Impact of Biosimilars in Healthcare and Cancer Treatment

In 2021, 91% of the 6.4 billion prescriptions written in the United States were for generic or biosimilar medications, with biosimilars alone saving the healthcare system $7 billion. Biosimilars are biological products that closely resemble FDA-approved reference products and have no significant clinical differences. Also known as follow-on biologics or biogenerics, biosimilars are made from living cells, which may cause slight differences in manufacturing, but they demonstrate similar safety, efficacy, and quality as their reference drugs through extensive clinical trials.

As of September 2022, 39 biosimilars have been approved, and 22 are on the market. These drugs offer substantial cost savings, typically 10-40% less than their reference biologics, making them a cost-effective treatment option for patients and healthcare providers. The biosimilar market has seen rapid growth, fueled by the expiration of patents for several biologic drugs and a rising demand for more affordable alternatives.

Developing biosimilars is a complex process. They undergo rigorous regulatory procedures to demonstrate their similarity to reference products, including head-to-head clinical trials. Biosimilars are used to treat a range of chronic conditions, including rheumatoid arthritis, anemia, inflammatory bowel disease, psoriasis, and cancer. They offer an opportunity for broader patient access, improving adherence and health outcomes.

In fact, FDA-approved biosimilars could save the healthcare system up to $250 billion in their first decade on the market. These savings stem from both the direct cost reduction of biosimilars and the increased competition that drives down prices for biologics.

Biosimilars are particularly promising in cancer treatment. Biologic drugs, often used in oncology, are expensive, limiting access to life-saving treatments for many patients, especially in developing countries. Biosimilars offer a more affordable alternative without sacrificing safety or effectiveness. Several biosimilars have been approved for cancer treatments, including those for breast cancer, colorectal cancer, and non-Hodgkin’s lymphoma. Biosimilars of granulocyte colony-stimulating factor (G-CSF) are also used to treat neutropenia, a common chemotherapy side effect.

In 2022, oncology applications accounted for the largest share of the biosimilars market, at around 24.29%, and are expected to continue growing rapidly in the coming years.

Biosimilars Market Top Companies
- Novartis
- Synthon Pharmaceuticals, Inc.
- TevaPharmaceutical Industries Ltd.
- LG Life Sciences
- Celltrion
- Biocon
- Hospira
- Merck Serono
- Biogen idec, Inc.
- Genentech
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/biosimilars-market

Access exclusive insight now @ https://www.towardshealthcare.com/price/5035

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
November 29, 2024
Newborn Eye Imaging Systems Market Key Players and Innovations
Newborn Eye Imaging Systems Market Overview

The newborn eye imaging systems market is projected to grow from USD 277.64 million in 2022 to USD 441.42 million by 2032, driven by the rising prevalence of Retinopathy of Prematurity (ROP) and increased healthcare spending.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5033

Growth Opportunities in Retinopathy of Prematurity (ROP) and Newborn Eye Imaging Systems
Ongoing research in Retinopathy of Prematurity (ROP) is creating significant growth opportunities in the newborn eye imaging market. These systems help detect eye disorders early, such as ROP, which can cause blindness if untreated. Early screening is crucial, as many vision issues can be addressed if diagnosed in infancy. The market is growing due to the increasing incidence of ROP, rising premature births, and expanding awareness of early screening programs. Technological advancements, such as higher-resolution imaging, are also driving market demand for these specialized systems in hospitals and clinics.

Key Companies in the Newborn Eye Imaging Systems Market

Visunex Medical Systems: A company focused on providing advanced retinal imaging systems for the early detection of eye diseases, particularly in neonates and infants. Their products are widely used in hospitals and clinics for retinal screening.

Eye Photo Systems: Known for its specialized eye imaging systems, Eye Photo Systems offers innovative solutions for capturing high-quality retinal images, especially in the context of newborn and pediatric eye care.

Merge Healthcare: A leading provider of medical imaging solutions, Merge Healthcare develops and delivers software and systems for the visualization and management of medical images, including those for newborn eye care.

D-EYE: This company focuses on portable retinal imaging devices, offering easy-to-use tools for eye screening. D-EYE systems are designed to be used by healthcare professionals for early diagnosis of conditions like Retinopathy of Prematurity (ROP).

Imagine Eyes: Specializes in high-resolution retinal imaging technologies. Imagine Eyes offers systems that provide detailed views of the retina, enabling early detection of eye disorders in newborns and children.

Natus Medical: A prominent player in the medical technology industry, Natus Medical provides neonatal care solutions, including advanced eye imaging systems for early diagnosis of eye diseases like ROP.

Servicom Medical: Servicom Medical develops medical imaging systems, including retinal imaging solutions that are vital for diagnosing and managing eye conditions in newborns and infants.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/newborn-imaging-systems-market

Access exclusive insight now @ https://www.towardshealthcare.com/price/5033

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
November 29, 2024
Biotechnology Industry Analysis Market Size and Key Players
Biotechnology Market Analysis Trends, Share and Applications
The global biotechnology market is poised for significant growth, expanding from an estimated USD 1,224.31 billion in 2022 to around USD 3,995.22 billion by 2032. This impressive growth, driven by a compound annual growth rate (CAGR) of 12.5% from 2023 to 2032, is fueled by continuous innovation and technological advancements within the biotechnology sector.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5034

Biotechnology: The Intersection of Biology and Technology

Steve Jobs once predicted that the greatest breakthroughs of the 21st century would emerge from the fusion of biology and technology—a vision that aptly describes the dynamic growth of the biotechnology industry today.

The global biotechnology market focuses on harnessing living organisms or biological systems to create innovative products, services, and technologies. These advancements are transforming fields such as healthcare, agriculture, and industrial applications. The industry spans diverse sectors, including biopharmaceuticals, genomics, proteomics, bioinformatics, synthetic biology, and bioprocessing.

In recent years, the biotechnology market has experienced rapid growth, driven by several key factors:

Rising demand for cutting-edge treatments for chronic diseases

Increasing investments in research and development

Technological advancements in genetic engineering and gene editing

Strong government support for biotechnology initiatives

These innovations have revolutionized industries, offering solutions to critical global challenges like disease, hunger, and climate change. Biotechnological advancements, such as genetic modification and DNA sequencing, are playing a pivotal role in shaping the future.

The market is set to grow even further in the coming years, fueled by increasing demand for biopharmaceuticals, the development of DNA sequencing technologies, and heightened investment in research. As the need for sustainable food production and effective treatments for chronic illnesses continues to rise, biotechnology stands at the forefront of addressing these pressing global issues.

Key Players in the Biotechnology Market

The biotechnology industry is driven by leading companies known for their innovative contributions and advancements across various sectors. Notable players in this market include:

Lonza: A global leader in biopharmaceutical development and manufacturing, offering solutions in cell and gene therapies.

AstraZeneca: Renowned for its focus on biotechnology-based therapies, particularly in oncology, respiratory, and cardiovascular diseases.

Pfizer Inc.: A major pharmaceutical company leveraging biotechnology for groundbreaking drugs and vaccines, including mRNA technology.

Gilead Sciences Inc.: A leader in antiviral therapies, specializing in treatments for HIV, hepatitis, and other viral diseases.

F. Hoffmann-La Roche Ltd.: Known for its innovations in diagnostics and biopharmaceuticals, particularly in oncology and personalized medicine.

Biogen: Focused on neuroscience, Biogen develops therapies for neurological disorders like multiple sclerosis and Alzheimer’s disease.

Celgene Corporation: Now a part of Bristol Myers Squibb, it is known for its advancements in oncology and immunology therapies.

Sanofi: A global leader in vaccines and biotechnology-based treatments for rare diseases and chronic conditions.

Abbott: Excelling in diagnostics and medical devices, Abbott utilizes biotechnology to enhance healthcare solutions.

Novartis AG: A pioneer in cell and gene therapies, Novartis integrates biotechnology into its innovative medicines pipeline.

Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/biotechnology-market

Access exclusive insight now @ https://www.towardshealthcare.com/price/5034

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
November 29, 2024
Brain-Computer Interface Market Innovations and Future Prospects
Brain-Computer Interface Market Outlook

The global brain-computer interface market is expected to grow from USD 2,130 million in 2022 to USD 9,445.1 million by 2032, at a 16.7% CAGR. Key drivers include rising neurodegenerative disorders and increased adoption in the gaming industry.

Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5036

Decoding Thoughts: The Brain-Computer Interface Market

The brain-computer interface (BCI) market focuses on developing systems that translate brain signals into commands for external devices, like robotic arms or computer cursors. Initially aimed at assisting paralyzed individuals, BCI applications now extend to fields like healthcare, gaming, and cognitive training.

Growth drivers include advancements in neuroscience, increased funding, and the potential to improve lives for those with disabilities. Challenges include technological complexity, ethical concerns, and regulatory hurdles.

Key applications, highlighted by the EU’s Horizon 2020 project, include enhancing motor recovery, enriching gaming experiences, controlling neuroprosthetics, enabling augmented reality, and advancing brain research. BCIs are poised to revolutionize industries and transform human-machine interactions.

Key Companies in the Brain-Computer Interface (BCI) Market
- OpenBCI
  Innovators in open-source hardware and software for BCI research and development, popular among developers and neurotechnology enthusiasts.
- Nihon Kohden Corporation
  A global leader in EEG systems, crucial for BCI applications, and other neurological diagnostic tools.
- NeuroSky
  Offers affordable, consumer-grade EEG devices for health, gaming, and educational purposes.
- Natus Medical Incorporated
  Provides advanced EEG systems and neurotherapy tools essential for BCI integration in healthcare.
- Integra LifeSciences
  Focuses on neurotechnology solutions, including implantable devices for BCI-related medical applications.
- g.tec Medical Engineering GmbH
  Specializes in real-time brain signal processing and neurorehabilitation solutions for BCI.
- Emotiv
  Develops wearable EEG devices and software, making BCI accessible for wellness, education, and research.
- Cortech Solutions
  Supplies advanced brain monitoring and neuroimaging tools for research and clinical BCI applications.
- Cadwell Industries
  Known for innovative neurodiagnostic equipment, including EEG systems for BCI development.
- Advanced Brain Monitoring, Inc.
  Focuses on neurotechnology for cognitive disorders and sleep studies, contributing to BCI advancements.
- Mind Technologies, Inc.
  Creates neurotechnology products aimed at mental health and cognitive enhancement.
- Covidien, Plc
  A division of Medtronic providing neurological and monitoring solutions relevant to BCI technologies.
- Compumedics, Ltd
  Produces diagnostic and monitoring equipment, including EEG systems vital for BCI applications.
- CAS Medical Systems
  Offers patient monitoring technologies with potential applications in BCI solutions.
- Others
  Numerous startups and smaller companies are driving innovation in BCI, expanding its applications in healthcare, gaming, and robotics.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/brain-computer-interface-market

Access exclusive insight now @ https://www.towardshealthcare.com/price/5036

We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com

Web: https://www.towardshealthcare.com

Visit Dental Specifics: https://www.towardsdental.com

Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription

For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
November 29, 2024